Regeneron Pharmaceuticals
An Associate Director in Oncology Clinical Development oversees clinical studies, ensures scientific integrity, and collaborates with cross-functional teams to support drug development in cancer therapies. The role involves leading scientific discussions, reviewing research documents, and contributing to program strategies within a regulated environment.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Oncology Clinical Development Scientist, Director
Pfizer
Clinical Sciences Leader, Global Clinical Oncology R&D
GSK plc
Medical Director, Early Clinical Development, Oncology
American Association of Physicists in Medicine
Clinical Scientist
Perspective Therapeutics
Senior Clinical Scientist, Oncology
Natera
Vice President, Clinical Development
Kura Oncology